Skip to main content
. 2020 Nov 12;12(11):1085. doi: 10.3390/pharmaceutics12111085

Table 2.

Selective physical modulation for circumventing the BBB in treating glioma.

Physical Modulation Physical Source Invasive or Noninvasive Tight Junction Effects Vesicular Transport Effects Clinical Stage Refs
Electromagnetic pulse (EMP) Electromagnetic radiation Noninvasive ZO-1↓, Occludin↓, Claudin-5↓, MMP-2↑, MMP-9↑ _ Preclinical [103,104,105,106,107,108]
Laser-induced thermal therapy (LITT) Laser Invasive, under anesthesia _ _ Clinical [109,110,111,112,113,114]
Radiotherapy: Synchrotron microbeam radiation therapy (MRT) X-ray beams Noninvasive ZO-1↓, Claudin-5↓, beta-catenin↓ _ Preclinical [115,116,117,118,119,120,121,122,123,124]
Focused ultrasound (FUS) Ultrasonic waves
with microbubbles
Noninvasive Occludin↓, Claudin-1↓, Claudin-5↓ Transport vesicles↑, Caveolin-1↑ Clinical [125,126,127,128,129,130,131,132,133,134,135,136]

Note: Up-regulated ↑; Down-regulated ↓.